A novel murine model for neuronopathic Gaucher diseaseMOLECULAR GENETICS AND METABOLISMIF3.52025-02-010PRE
Genome-edited autologous stem cell transplantation with enhanced brain conditioning to correct progranulin deficiencyMOLECULAR GENETICS AND METABOLISMIF3.52025-02-010PRE
Correction of GD1 pathology by genome edited murine hematopoietic stem cell transplantationMOLECULAR GENETICS AND METABOLISMIF3.52025-02-010PRE
Hematopoietic stem cell transplantation for lysosomal disorders: Unraveling the mechanisms for CNS repopulationMOLECULAR GENETICS AND METABOLISMIF3.52025-02-010PRE
Investigational new drug-enabling studies for genome-edited hematopoietic stem cells to treat mucopolysaccharidosis type IMOLECULAR GENETICS AND METABOLISMIF3.52025-02-010PRE
Genome-edited hematopoietic stem cells as a curative approach for Gaucher disease type 1MOLECULAR GENETICS AND METABOLISMIF3.52024-02-010PRE